510(k) Report

510(k) · Cleared

Recalled · Class I · 2018

Fresenius Naturalyte Granuflo Dry Acid Concentrate 10XX Series, 24XX Series, 30XX Series

K030497510(k) TraditionalCleared May 20, 200390-day reviewClass II21 CFR 876.5820Recalls 14 (2 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Fresenius Medical Care · KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder)

Cleared on May 20, 2003 as substantially equivalent to K911459 (Fresenius USA, Inc., 1991) and 1 other predicate after a 90-day review. Its family tree reaches back 1 generation to 1991. 1 of the 4 devices in its family, counting itself, has a Class I recall. 1 later device descends from it. It has been recalled 14 times, including 2 Class I recalls.

Decided
May 20, 2003
Review
90 days
Class
Class II
Product code
KPO
Recalls
14 (2 Class I)
Predicates
2

Its longest line of descent runs back 1 generation to K911459 (1991). 2 ancestors in all. 1 later device descends from it, 1 citing it directly. 1 of the 4 devices in this family, counting this one, has a Class I recall.

Other ancestors, by year clearedDescendants, by year cleared 1994: 1 other ancestor2020: 1 descendant clearedK911459 · Granulyte Powder Dialysate Concentrate and Mixing · Fresenius USA, Inc. · 1991 · recalled1990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant K911459 · Granulyte Powder Dialysate Concentrate and Mixing · Fresenius USA, Inc. · 1991 · recalled0
  1. Root · 1 generation backK911459 Granulyte Powder Dialysate Concentrate and MixingFresenius USA, Inc. · 1991 · Recalled
  2. This deviceK030497 Fresenius Naturalyte Granuflo Dry Acid Concentrate 10XX Series, 24XX…Fresenius Medical Care · 2003
  3. Descendant · cites it directly · 0 of its ownK192209 Citrasate Dry Acid Concentrate, Granuflo Dry Acid ConcentrateFresenius Medical Care Renal Therapies Group, LLC · 2020 · Recalled

Most influential descendants

Showing 1 of 1 · See all
  • K192209Citrasate Dry Acid Concentrate, Granuflo Dry Acid ConcentrateFresenius Medical Care Renal Therapies Group, LLC · 2020 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K911459Granulyte Powder Dialysate Concentrate and MixingFresenius USA, Inc.19912
0 (this device)K030497Fresenius Naturalyte Granuflo Dry Acid Concentrate 10XX Series, 24XX Series…Fresenius Medical Care2003—
+1K192209Citrasate Dry Acid Concentrate, Granuflo Dry Acid ConcentrateFresenius Medical Care Renal Therapies Group, LLC20202

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
FIG. 1 — Lineage of K030497, 1991–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KPO device

  1. #1 K233159 pureFLOW 402, pureFLOW 400, pureFLOW 406…score 14.5 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K911459Granulyte Powder Dialysate Concentrate and Mixing
Summary page 1
…lysis (liquid or powder) - Class I1 Device Product Code and Panel Code: KPO, 78 Predicate Device(s): Granulyte Powder Dialysate Concentrates and Mixer; (K9 1 1459, SE 07/17/1991); Granulyte Dialysate Concentrate; (K922005, SE 03/30/94) Description: The Fresenius Natural…
Fresenius USA, Inc.19912
*K922005Granulyte Dialysate Concentrate
Summary page 1
…Code: KPO, 78 Predicate Device(s): Granulyte Powder Dialysate Concentrates and Mixer; (K9 1 1459, SE 07/17/1991); Granulyte Dialysate Concentrate; (K922005, SE 03/30/94) Description: The Fresenius NaturalyteO GranufloO Dry Acid Concentrate is designed to be used as direct product rep…
Fresenius USA, Inc.1994—

Also cleared against K911459: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K192209Citrasate Dry Acid Concentrate, Granuflo Dry Acid ConcentrateFresenius Medical Care Renal Therapies Group, LLC20200

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 9, 2018Class IIIZ-0516-2019Under Investigation by firmDiscolored powder has confirmed the presence of a foreign substance
Oct 9, 2018Class IIIZ-0518-2019Under Investigation by firmDiscolored powder has confirmed the presence of a foreign substance
Oct 9, 2018Class IIIZ-0517-2019Under Investigation by firmDiscolored powder has confirmed the presence of a foreign substance
Nov 26, 2012Class IIIZ-0677-2013Nonconforming Material/ComponentGranuFlo Dry Acid Concentrate may show discoloration
Nov 26, 2012Class IIIZ-0678-2013Nonconforming Material/ComponentGranuFlo Dry Acid Concentrate may show discoloration
Nov 26, 2012Class IIIZ-0681-2013Nonconforming Material/ComponentGranuFlo Dry Acid Concentrate may show discoloration
Nov 26, 2012Class IIIZ-0682-2013Nonconforming Material/ComponentGranuFlo Dry Acid Concentrate may show discoloration
Nov 26, 2012Class IIIZ-0676-2013Nonconforming Material/ComponentGranuFlo Dry Acid Concentrate may show discoloration
Nov 26, 2012Class IIIZ-0679-2013Nonconforming Material/ComponentGranuFlo Dry Acid Concentrate may show discoloration
Nov 26, 2012Class IIIZ-0680-2013Nonconforming Material/ComponentGranuFlo Dry Acid Concentrate may show discoloration
Nov 26, 2012Class IIIZ-0683-2013Nonconforming Material/ComponentGranuFlo Dry Acid Concentrate may show discoloration
Nov 26, 2012Class IIIZ-0684-2013Nonconforming Material/ComponentGranuFlo Dry Acid Concentrate may show discoloration
Mar 29, 2012Class IZ-1827-2012Labeling False and MisleadingRisk of Alkalosis with acetate containing dialysis acid concentrates
Mar 29, 2012Class IZ-1826-2012Labeling False and MisleadingRisk of Alkalosis with acetate containing dialysis acid concentrates

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K192209 (Fresenius Medical Care Renal Therapies Group, LLC, 2020) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K911459.

How does its category compare?

All KPO devices

KPO Dialysate Concentrate For Hemodialysis (Liquid Or Powder): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KPO

2in 2025

2007: 22008: 22009: 12011: 12012: 22013: 12014: 22015: 12016: 12017: 32018: 22020: 52021: 12022: 22023: 32024: 32025: 22026 (partial year): 2
2007high 5 (2020) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KPO

112in 2024

2017: 192 days median2020: 270 days median2023: 263 days median2024: 112 days median
2007high 270 (2020) · low 112 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KPO

6in 2025

2007: 52008: 22009: 12011: 22012: 102015: 32016: 12017: 12018: 112019: 12020: 312022: 22024: 12025: 62026 (partial year): 9
2007high 31 (2020) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KPO

95in 2025

2007: 52008: 82009: 32010: 1072011: 2232012: 702013: 3,8972014: 15,9162015: 8,3402016: 2402017: 802018: 972019: 792020: 2442021: 632022: 252023: 592024: 2592025: 95
2007high 15,916 (2014) · low 3 (2009)2025

MAUDE reports naming product code KPO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—55
20082—28
20091—13
20100—0107
20111—2223
20122—1070
20131—03,897
20142—015,916
20151—38,340
20161—1240
20173192180
20182—1197
20190—179
2020527031244
20211—063
20222—225
20233263059
202431121259
20252—695
20262—9—

What is it indicated for?

The Fresenius NaturalyteO GranufloO Dry Acid Concentrate is indicated in the treatment of acute and chronic renal failure durjng the hemodialysis procedure. This concentrate is formulated to be used with a three-stream hemodialysis machine which is calibrated for acid and bicarbonate concentrates.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K030497: Fresenius Naturalyte Granuflo Dry Acid Concentrate 10XX Series, 24XX Series, 30XX Series.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K030497

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026